Ultime notizie per Beyond Air (NASDAQ:XAIR) Azioni

Beyond Air

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Beyond Air Inc

Needham analyst Mike Cikos assumes Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Buy rating and announces Price Target of $240.

News

Price Target

Initiation

Analyst Ratings

Needham Assumes Zscaler at Buy, Announces Price Target of $240

Under the Agreement, the Company will indirectly acquire the Data Centers and BTC Mining Machines for a total consideration of US$14.28 million. The consideration comprises a cash payment of US$2.265 million and the issuance of Class A ordinary shares of the Company with a par value of US$0.00005 per share, amounting to an aggregate value of US$12.015 million.

BTCM

BIT Mining To Acquire Ethiopian Crypto Mining Data Centers And 17,869 Bitcoin Machines For $14.28M

Morgan Stanley analyst Angel Castillo initiates coverage on AGCO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>) with a Equal-Weight rating and announces Price Target of $101.

AGCO

Morgan Stanley Initiates Coverage On AGCO with Equal-Weight Rating, Announces Price Target of $101

Tesla Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) insurance registrations in China reached 18,600 units for the week ending Dec. 1, indicating robust demand in one of the electric vehicle maker&#8217;s key markets, according to data shared by industry analysts.
What Happened: The Future Fund LLC Managing Partner Gary Black said that Tesla China&#8217;s fourth quarter performance is showing significant growth, with registrations up 14.2% year-over-year and 5.8% quarter-over-quarter. The current trajectory suggests this could be Tesla China&#8217;s strongest quarter to date.
Recent weekly registration data has shown consistent strength, with numbers holding steady above 16,700 units throughout November. The latest figure of 18,600 units represents a notable improvement from previous weeks&#8217; registrations of 17,300, 17,100, and 16,700 units.
Historical data reveals substantial growth in Tesla&#8217;s Chinese market presence. Insurance registrations jumped from 440,793 units in 2022 to 610,074 units in 2023, demonstrating the company&#8217;s expanding foothold in the world&#8217;s largest automotive market. The 2024 projections indicate continued growth, with weekly registrations consistently outpacing previous years.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> China recorded 18.6K insured registrations for the week of Nov 25-Dec 1. After 9 weeks, 4th qtr is +14.2% YoY, +5.8% QoQ, and in position to be TSLA China's best qtr ever. Source: <a href="https://twitter.com/piloly?ref_src=twsrc%5Etfw">@piloly</a> <a href="https://twitter.com/Tslachan?ref_src=twsrc%5Etfw">@Tslachan</a> <a href="https://t.co/PxSmR404oL">pic.twitter.com/PxSmR404oL</a>
&mdash; Gary Black (@garyblack00) <a href="https://twitter.com/garyblack00/status/1863844453351411861?ref_src=twsrc%5Etfw">December 3, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/24/12/42283257/charles-schwab-goldman-sachs-invesco-add-mara-holdings-morgan-stanley-cuts-stake-here-is-what-changed-with-mara-holdings-in-q3">Charles Schwab, Goldman Sachs Boosts MARA Stake As Stock Rallies 30% In Past 6 Months</a>
Why It Matters: This positive momentum comes as Tesla faces challenges in other areas. The company recently confirmed it has no immediate plans to introduce its newly launched Cybertruck in China, according to Chinese media outlet Jiemian. CEO Elon Musk <a href="https://www.benzinga.com/24/12/42282544/tesla-has-no-plans-to-sell-cybertruck-in-china-report">previously cited potential regulatory hurdles</a> for the stainless steel vehicle in the Chinese market.
Tesla&#8217;s Shanghai gigafactory, which produces the company&#8217;s mass-market Model 3 and Model Y vehicles, has been crucial to its success in China. Unlike the premium Model S and Model X, which are imported, these locally manufactured vehicles have helped Tesla capture a significant share of China&#8217;s growing electric vehicle market.
The strong insurance registration numbers suggest Tesla continues to maintain robust demand in China despite increasing competition from local manufacturers and global economic uncertainties.
Price Action: Tesla stock closed at $357.09 on Monday, up 3.46%, for the day. In after-hours trading, the stock dipped 1.23%. Year to date, Tesla&#8217;s stock has surged 43.74%, according to <a href="https://www.benzinga.com/pro/">data from Benzinga Pro</a>.
Tesla has a consensus price target of $246.16 based on 34 analysts. The highest target is $411, and the lowest is $24.86. Recent ratings from Roth MKM, Stifel, and UBS suggest an average target of $339, implying a 5% downside, according to <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">data from Benzinga Pro</a>.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/TSLA/analyst-ratings"><img loading="lazy" decoding="async" width="474" height="356" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03040325/Tesla-ratings.jpg" alt="" class="wp-image-674066" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03040325/Tesla-ratings.jpg 474w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/03040325/Tesla-ratings-300x225.jpg 300w" sizes="(max-width: 474px) 100vw, 474px" /></a></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42282266/cathie-wood-led-arks-prediction-ai-will-turn-digital-wallets-into-9-trillion-e-commerce-powerhouses-google-amazon-dominance-set-for-disruption">Cathie Wood-Led Ark&#8217;s Prediction: AI Will Turn Digital Wallets Into $9 Trillion E-Commerce Powerhouses — Google, Amazon Dominance Set For Disruption?</a></li>
</ul>
Image via Tesla
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Global

Markets

Tech

TSLA

Tesla China Sees Robust Demand In Q4, With Registrations Up 14.2% YoY So Far: Expert Says EV Giant On Track For 'Best Quarter Ever'

Wipro And Netskope Partner To Deliver Cybersecurity Optimization Services For Global Enterprises

RBC Capital analyst Scott Hanold reinstates EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) with a Sector Perform and announces $49 price target.

RBC Capital Reinstates Sector Perform on EQT, Announces $49 Price Target

LOGI

Logitech G Partners With Airdrop Gaming To Enhance Accessibility For Deaf And Hard Of Hearing Gamers

Morgan Stanley analyst Meta Marshall upgrades Axon Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) from Equal-Weight to Overweight and raises the price target from $500 to $700.

Upgrades

AXON

Morgan Stanley Upgrades Axon Enterprise to Overweight, Raises Price Target to $700

<a href="https://cnevpost.com/2024/12/03/tesla-china-sells-78856-cars-nov-2024/" title="https://cnevpost.com/2024/12/03/tesla-china-sells-78856-cars-nov-2024/">https://cnevpost.com/2024/12/03/tesla-china-sells-78856-cars-nov-2024/</a>

China Passenger Car Association Said Tesla Sold 78,856 China-Made Vehicles In November Up 15.49% Vs October; Down 4.34% Vs November 2023

Elon Musk&#8216;s rocket manufacturing company SpaceX is reportedly in talks to sell insider shares of the company that could boost its valuation to about $350 billion.
What Happened: The talks are ongoing and details of the transaction could differ depending upon interest from insider sellers and buyers, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-12-02/spacex-discusses-tender-offer-at-roughly-350-billion-valuation">reported</a>, citing people familiar with the matter.
A report in November suggested that SpaceX was <a href="https://www.benzinga.com/24/11/42022150/spacex-to-launch-tender-offer-valuing-company-at-over-250-billion-report">aiming for a $250 billion valuation</a>, but it has since been raised to $350 billion, according to media reports.
SpaceX was valued at about <a href="https://www.benzinga.com/news/24/06/39519229/elon-musk-dismisses-rumors-of-spacex-ipo-as-it-reportedly-seeks-210b-valuation-pressure-for-short-te">$210 billion in a tender offer earlier this year</a>. A valuation of about $350 billion will make the company the most valuable private startup in the world. 
SpaceX is privately held, unlike Musk&#8217;s Tesla which is a publicly listed company. The secondary offering gives shareholders the choice of selling shares they hold in the company and generating liquidity. 
Why It Matters: Musk has&nbsp;<a href="https://www.benzinga.com/news/24/06/39519229/elon-musk-dismisses-rumors-of-spacex-ipo-as-it-reportedly-seeks-210b-valuation-pressure-for-short-te" target="_blank" rel="noreferrer noopener">previously dismissed</a>&nbsp;the possibility of a SpaceX initial public offering (IPO), citing the intense pressure for short-term results faced by publicly listed companies.
Company COO Gwynne Shotwell said at a conference hosted by Baron Capital last month that the company will make "some money" on Starlink this year. Starlink is the satellite internet segment of SpaceX. It achieved a&nbsp;<a href="https://www.benzinga.com/news/23/11/35583773/spacex-ceo-elon-musk-says-starlink-business-has-achieved-breakeven-cash-flow-is-an-ipo-on-the-cards" target="_blank" rel="noreferrer noopener">breakeven cash flow</a>&nbsp;in November 2023.
"We are going to make some money on Starlink this year. But ultimately I think Starship (the company&#8217;s new rocket under development) will be the thing that takes us over the top as one of the most valuable companies," she said. However, Shotwell refused to divulge more of the company's financials.
Investors can leverage Destiny Tech100 Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXYZ#NYSE">DXYZ</a>) and Cathie Wood‘s Ark Venture Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKVX#NASDAQ">ARKVX</a>) to participate in SpaceX&#8217;s growth.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42283241/gm-to-sell-its-stake-in-jvs-new-battery-cell-plant-in-lansing-to-lg-energy-solution">GM To Sell Stake In Michigan Battery Plant To JV Partner For Nearly $1B</a></li>
</ul>
Photo courtesy: SpaceX

SPACE

ARKVX

DXYZ

SpaceX Reportedly Considers Tender Offer Valuing It At $350B, Surging From $210B In Previous Stake Sale

Needham analyst Mike Matson reiterates TransMedics Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) from Hold to Hold.

Reiteration

TMDX

Needham Reiterates Hold on TransMedics Grto Hold

<ul>
<li>The conditional approval by the NMPA was supported by registration stage data from FRUSICA-1, the endometrial cancer registration cohort of a multi-center, open-label Phase II study investigating fruquintinib in combination with sintilimab in endometrial cancer patients who have experienced disease recurrence, disease progression or intolerable toxicity with treatment on platinum-based doublet chemotherapy.&nbsp;</li>
<li>Results from FRUSICA-1 were presented at the American Society of Clinical Oncology annual meeting in June 2024.</li>
<li>The study results showed that IRC-assessed objective response rate and disease control rate was 35.6% and 88.5% respectively.&nbsp;</li>
<li>The combination treatment showed rapid on-set efficacy, with a median time to response of only 1.6 months.&nbsp;</li>
<li>The median progression-free survival and overall survival reached 9.5 months and 21.3 months respectively.&nbsp;</li>
</ul>

Biotech

Health Care

General

Hutchmed And Innovent Biologics Announce That Elunate (Fruquintinib) And Tyvyt (Sintilimab) Combination Has Received Conditional Approval In China For Advanced Endometrial Cancer With Mismatch Repair Proficient Tumors That Have Failed Prior Systemic Therapy And Are Not Candidates For Curative Surgery Or Radiation

According to the agreement, MMV will hold 80% of the shares of the to-be-formed joint - venture company, Zhao Mingwei will hold 10% of the shares, and Li Yuanfeng will hold the remaining 10%. The board of directors will be composed of executives appointed by the three parties. The new company will purchase Bitcoin and purchase Bitcoin mining machines.

Eaton Vance Massachusetts Municipal Income Trust

MultiMetaVerse Joins Forces With Zhao Mingwei And Li Yuanfeng To Launch Digital Currency Investment Company

Needham analyst Gil Blum reiterates Cartesian Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAC#NASDAQ">RNAC</a>) with a Buy and maintains $41 price target.

RNAC

Needham Reiterates Buy on Cartesian Therapeutics, Maintains $41 Price Target

An influential cryptocurrency analyst expressed hope Monday that despite growing concerns of a strong pullback, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) might actually surge in the days ahead.
What Happened: Ali Martinez, known for identifying chart patterns and coming up with price predictions, noted how some influencers were anticipating a price decline. 
He cited widely-followed analysts Sheldon The Sniper and Tone Vays, who forecast Bitcoin&#8217;s dip below $90,000. Vays ruled out the possibility of a $100,000 breach in 2024.
Martinez added that the crowd has reacted to these bearish predictions, with data from on-chain analytics firm Santiment showing a high volume of &#8220;BTC pullback&#8221; mentions on social media.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">From time to time, I check what some of my favorite analysts are thinking to see if I'm missing something. And right now, I think I'm missing something. Many are talking about a potential <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> price crash… &#x1f440;&#x1f440;&#x1f440; Here's what they are saying &#x1f447;&#x1f9f5;
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1863526628497694839?ref_src=twsrc%5Etfw">December 2, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Interestingly, Martinez took a bullish position based on the premise that Bitcoin often behaves contrary to popular belief.
&#8220;If the current cycle behaves like the last two, BTC could go to $120,000-$150,000 before the first 30% price correction,&#8221; he predicted.
However, he cautioned about two key support levels at $93,580 and $90,520, which if breached would invalidate his bullish thesis.
See Also:&nbsp;<a href="https://www.benzinga.com/24/12/42282353/the-bitcoin-playbook-mara-doubles-market-cap-stock-price-in-last-three-months">Michael Saylor Says MARA On The &#8216;Bitcoin Standard&#8217; As Company Doubles Market Cap, Stock Price In Last 3 Months</a>
Why It Matters: Martinez&#8217;s balanced viewpoint comes <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42281558/bitcoin-ethereum-dogecoin-dip-as-investors-get-spooked-by-us-governments-2b-btc-transfer-analyst-says-breakout-above-100k-could-trigger-20-25-correction-in-top-crypto">amid a pause in Bitcoin&#8217;s upward trajectory</a> following the U.S. government transfer of nearly $2 billion worth of BTCs to different addresses.
While the intention of the transfer was not yet evident, such movements invariably spook investors, who interpret them as selling events.
Data from IntoTheBlock <a href="https://app.intotheblock.com/">showed</a> a 125% jump in large Bitcoin transactions in the last 24 hours. Additionally, the balance held by long-term holders of the coin dipped, indicating that they were cashing out.
Price Action: At the time of writing, Bitcoin was trading at $95,507.14, up 0.26% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42282930/cleanspark-sheds-light-on-bitcoin-acquisition-strategy-says-investments-in-core-business-contribute-the-most-to-shareholder-value">CleanSpark CEO Zach Bradford Explains Why The Company Is Betting on Bitcoin Mining, Not Buying</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Top Crypto Analyst Foresees Potential Bitcoin Surge To This Level Amid Rising Pullback Worries

Needham analyst Ami Fadia reiterates Revolution Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVMD#NASDAQ">RVMD</a>) with a Buy and maintains $68 price target.

RVMD

Needham Reiterates Buy on Revolution Medicines, Maintains $68 Price Target

Bernstein analyst Alexia Howard initiates coverage on Lamb Weston Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) with a Market Perform rating and announces Price Target of $85.

Bernstein Initiates Coverage On Lamb Weston Hldgs with Market Perform Rating, Announces Price Target of $85

BMO Capital analyst Kelly Bania downgrades Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) from Outperform to Market Perform and maintains the price target from $60 to $60.

Downgrades

BMO Capital Downgrades Kroger to Market Perform, Maintains Price Target to $60

Bernstein analyst David Vernon downgrades FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) from Outperform to Market Perform and lowers the price target from $337 to $316.

Bernstein Downgrades FedEx to Market Perform, Lowers Price Target to $316

Keefe, Bruyette &amp; Woods analyst David Konrad upgrades Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) from Market Perform to Outperform and raises the price target from $70 to $82.

Keefe, Bruyette & Woods Upgrades Citigroup to Outperform, Raises Price Target to $82

Reports Q2 revenue $798,000, consensus $1.04M. "Our commercial strategy continued to drive results throughout the quarter with our total number of ...

Beyond Air reports Q2 EPS (28c), consensus (28c)

Beyond Air, Inc. (XAIR) Q2 2025 Earnings Call Transcript

In a report released yesterday, Marie Thibault from BTIG reiterated a Hold rating on Beyond Air (XAIR – Research Report). The company's shares clos...

BTIG Keeps Their Hold Rating on Beyond Air (XAIR)

Piper Sandler analyst Jason Bednar assigned a Buy rating to Beyond Air (XAIR – Research Report) today and set a price target of $1.00. The company'...

Piper Sandler Releases a Buy Rating on Beyond Air (XAIR)

Ladenburg lowered the firm's price target on Beyond Air (XAIR) to $2 from $4 and keeps a Buy rating on the shares after fiscal Q2 revenues of $0.8M...

Beyond Air price target lowered to $2 from $4 at Ladenburg

Beyond Air ( ($XAIR) ) has released its Q2 earnings. Here is a breakdown of the information Beyond Air presented to its investors. Beyond Air, Inc....

Beyond Air Reports Increased Revenue Amid Financial Challenges

Beyond Air (XAIR) has disclosed a new risk, in the Share Price & Shareholder Rights category. Beyond Air faces a critical risk regarding its abilit...

Beyond Air Faces Nasdaq Delisting Threat: Stock Price and Liquidity at Risk

NeuroNOS, a subsidiary of Beyond Air (XAIR), announces the appointment of Professor Roger Kornberg, to its Scientific Advisory Board, SAB. This app...

Beyond Air's NeuroNOS appoints Kornberg to SAB

Beyond Air ( ($XAIR) ) has shared an update. Beyond Air, Inc.'s 2025 Annual Meeting saw stockholders approving significant changes to the 2013 Equi...

Beyond Air Approves Key Changes at Annual Meeting

Beyond Air (XAIR) announced European CE mark approval of the LungFit PH system. This CE mark approval allows Beyond Air to market LungFit PH in the...

Beyond Air receives CE Mark for LungFit PH System

XAIR

Financing

Press Releases

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

Contracts

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Comments

Beyond Air

Notizie

Ultime notizie per Beyond Air (NASDAQ:XAIR) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO